Skip to main content
Fig. 5 | BMC Complementary and Alternative Medicine

Fig. 5

From: Evaluation of the immunomodulatory effects of a South African commercial traditional immune booster in human peripheral blood mononuclear cells

Fig. 5

Soluble IL-2 receptor levels in supernatants of cyclosporine-immunosuppressed (A), PHA-stimulated (B), and PG-S. aureus-stimulated (C) PBMCs treated with uMakhonya® doses (100 and 10 μg/mL) over 24 h. In immunosuppressed and PHA-stimulated samples, addition of uMakhonya® significantly increased (p < 0.05) sIL-2R levels compared to untreated and cyclosporine-suppressed samples. In PG-S. aureus-stimulated samples, the addition of uMakhonya® caused a significant decrease (p < 0.05) in sIL-2R level when compared to samples stimulated with PG-S. aureus only. The highest dose of uMakhonya® (100 μg/mL) was more effective (p <0.05) at reducing sIL-2R in PG-S. aureus-stimulated samples than cyclosporine

Back to article page

BMC Complementary Medicine and Therapies

ISSN: 2662-7671

Contact us